CNS Pharmaceuticals, Inc. SEC filings CNSP
CNS Pharmaceuticals, Inc. has 390 filings in SEC EDGAR's recent list, going back to Mar 13, 2018. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Aug 18, 2026 | May 18, 2026 |
| 3 | Initial insider ownership | Aug 18, 2026 | May 4, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 17, 2026 | — |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 3 | Initial insider ownership | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 3 | Initial insider ownership | Mar 4, 2026 | Mar 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Jan 2, 2026 | Jan 1, 2026 |
| 3 | Initial insider ownership | Jan 2, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Aug 6, 2024 | Jul 30, 2024 |
| 3 | Initial insider ownership | Aug 6, 2024 | Jul 29, 2024 |
| SC 13D | Ownership over 5% (active) | Aug 2, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jul 2, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jun 25, 2024 | — |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 6, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 6, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 6, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 6, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 6, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 6, 2024 | Feb 1, 2024 |
| 4/A | Filing | Oct 12, 2023 | Sep 21, 2023 |
| 4/A | Filing | Oct 12, 2023 | Sep 21, 2023 |
| 4/A | Filing | Oct 12, 2023 | Sep 21, 2023 |
| 4/A | Filing | Oct 12, 2023 | Sep 14, 2023 |
| 4/A | Filing | Oct 12, 2023 | Sep 21, 2023 |
| 4/A | Filing | Oct 12, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Aug 23, 2023 | Aug 22, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 16, 2023 |
| 4/A | Filing | Aug 10, 2023 | May 5, 2023 |
| 4 | Insider transaction | Aug 1, 2023 | Dec 6, 2022 |
| SC 13G | Ownership over 5% (passive) | Aug 1, 2023 | — |
| 4 | Insider transaction | May 9, 2023 | May 5, 2023 |
| 3 | Initial insider ownership | May 9, 2023 | May 3, 2023 |
| 4 | Insider transaction | May 1, 2023 | Apr 28, 2023 |
| 4 | Insider transaction | May 1, 2023 | Apr 28, 2023 |
| 4 | Insider transaction | Apr 21, 2023 | Apr 19, 2023 |
| 4 | Insider transaction | Apr 18, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 17, 2023 | Apr 10, 2023 |
| 4 | Insider transaction | Apr 14, 2023 | Apr 12, 2023 |
| 4 | Insider transaction | Mar 31, 2023 | Mar 29, 2023 |
| 4 | Insider transaction | Mar 31, 2023 | Mar 29, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| 4 | Insider transaction | Jan 4, 2023 | Dec 30, 2022 |
| 3 | Initial insider ownership | Jan 4, 2023 | Dec 30, 2022 |
| 4 | Insider transaction | Apr 29, 2022 | Apr 28, 2022 |
| 4 | Insider transaction | Apr 29, 2022 | Apr 28, 2022 |
| 4 | Insider transaction | Mar 14, 2022 | Mar 11, 2022 |
| 4 | Insider transaction | Mar 9, 2022 | Mar 7, 2022 |
| 4 | Insider transaction | Mar 9, 2022 | Mar 8, 2022 |
| 4 | Insider transaction | Mar 8, 2022 | Mar 7, 2022 |
| 4 | Insider transaction | Jan 25, 2022 | May 5, 2020 |
| 4 | Insider transaction | Dec 7, 2021 | Dec 6, 2021 |
| 4 | Insider transaction | Nov 22, 2021 | Nov 19, 2021 |
| 4 | Insider transaction | Nov 18, 2021 | Nov 16, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Feb 9, 2021 | Feb 5, 2021 |
| 4 | Insider transaction | Feb 9, 2021 | Feb 5, 2021 |
| 4 | Insider transaction | Aug 25, 2020 | Aug 24, 2020 |
| 4 | Insider transaction | Jun 16, 2020 | Jun 12, 2020 |
| 4 | Insider transaction | Jun 16, 2020 | Jun 12, 2020 |
| 4 | Insider transaction | Jun 16, 2020 | Jun 12, 2020 |
| 4 | Insider transaction | Jun 16, 2020 | Jun 12, 2020 |
| 4 | Insider transaction | Nov 13, 2019 | Nov 13, 2019 |
| 3 | Initial insider ownership | Nov 13, 2019 | Nov 13, 2019 |
| 3 | Initial insider ownership | Nov 8, 2019 | Nov 7, 2019 |
| 3 | Initial insider ownership | Nov 8, 2019 | Nov 7, 2019 |
| 3 | Initial insider ownership | Nov 8, 2019 | Nov 7, 2019 |
| 3 | Initial insider ownership | Nov 8, 2019 | Nov 7, 2019 |
| 3 | Initial insider ownership | Nov 8, 2019 | Nov 7, 2019 |
| 3 | Initial insider ownership | Nov 8, 2019 | Nov 7, 2019 |
Showing 104 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1729427
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.